Milan develops cell therapy against ischemic heart disease
The development of cell therapy for refractory angina has entered a decisive phase as an Italian investor begins work on an innovative patent.
The development of cell therapy for refractory angina has entered a decisive phase as an Italian investor begins work on an innovative patent.
As a result of this new approach involving widened blood vessels, blood flows to the place where it is most needed in the body after a heart attack or stroke much more quickly.
Scientists from Germany and Australia have developed an ultra-thin endoscope using a 3D printer.
UPDATE FROM THE EDITORS: We would like to inform our readers that the studies mentioned in the following text have been withdrawn at the request […]
UPDATE FROM THE EDITORS: We would like to inform our readers that the studies mentioned in the following text have been withdrawn at the request […]